Galera Therapeutics, Inc. (GRTX) - Insider Holders & Insider Ownership

List of insiders holdings for Galera Therapeutics, Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Emerald Bioventures LLC
Opler Timothy
10% Owner		2026-05-29 16:58:2661,029,978
0		61,029,978Form 13D
2Schneid Yair
10% Owner		2024-05-16 10:26:1710,823,610
0		10,823,610Form 13G
3Soffer Rochel
ALPHA PHARMA Investments LLC
10% Owner		2024-05-16 10:26:453,178,137
2,750,000		5,928,137Form 3
4New Enterprise Associates 14 L.P.
Sonsini Peter W.
KERINS PATRICK J
NEA Partners 14 L.P.
NEA 14 GP LTD
BARRIS PETER J
BASKETT FOREST
Florence Anthony A. Jr.
MOTT DAVID M
SANDELL SCOTT D
10% Owner		2020-02-13 10:50:024,358,042
0		4,358,042Form 13G
5Blackstone Clarus GP L.P.
Blackstone Clarus GP L.L.C.
Blackstone Holdings II L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Group Inc
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner		2023-12-04 16:32:022,289,605
0		2,289,605Form 13D
6Novo Holdings A/S
10% Owner		2023-06-28 16:19:562,100,000
0		2,100,000Form 13G
7Novartis Bioventures Ltd
NOVARTIS AG
Former 10% Owner		2022-02-11 16:30:53476,085
0		476,085Form 13G
8Keene Jeffrey
10% Owner		2019-11-06 17:27:59172,238
0		172,238Form 3
9Stacey Jennifer Evans
See Remarks		2023-02-28 18:56:05135,000
0		135,000Form 4
10Beardsley Robert A
Chief Operating Officer		2023-02-28 19:06:09135,000
0		135,000Form 4
11Clarus IV-A L.P.
Clarus IV-B L.P.
Clarus IV-C L.P.
Clarus IV-D L.P.
Clarus IV GP L.P.
10% Owner		2019-11-14 17:00:590
130,444		130,444Form 4
12HOLMLUND JON T
Chief Medical Officer		2022-03-02 16:05:4675,000
0		75,000Form 4
13Fratamico Arthur
Chief Business Officer		2021-01-28 16:05:0975,000
0		75,000Form 4
14Matthes Catherine L.
10% Owner		2019-11-06 17:24:248,503
66,184		74,687Form 3
15Riley Dennis
Chief Scientific Officer		2020-02-04 18:00:4374,435
0		74,435Form 4
16POWELL MICHAEL
Director		2023-06-16 16:15:3564,000
0		64,000Form 4
17Buckler Regina A.
10% Owner		2019-11-06 17:28:5462,254
0		62,254Form 3
18Wood Brian
10% Owner		2019-11-06 17:32:3462,137
0		62,137Form 3
19Brill Jeffrey
10% Owner		2019-11-06 17:31:5162,137
0		62,137Form 3
20Schall Otto
10% Owner		2019-11-06 17:20:1055,137
0		55,137Form 3
21Kennedy Eugene P.
Chief Medical Officer		2023-02-28 18:57:3455,000
0		55,000Form 4
22Ross Stephen A
10% Owner		2019-11-06 17:21:5846,622
0		46,622Form 3
23West Linda
Director		2023-07-05 16:11:0223,382
0		23,382Form 4
24Fuller Jason
Director		2019-11-08 19:49:1319,776
0		19,776Form 4
25Bachleda Mark
Chief Commercial Officer		2023-03-20 16:05:1711,000
0		11,000Form 4
26Degnan Chris
Chief Financial Officer		2023-03-14 08:30:0910,000
0		10,000Form 4
27Cunningham Emmett
Director		2023-06-16 16:15:100
0		0Form 4
28Altamont Pharmaceutical Holdings LLC
Pearson Mark E.
10% Owner		2024-04-03 08:08:380
0		0Form 13G
29Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
POWELL MICHAEL
HEALY JAMES
Mehra Anand
10% Owner		2024-02-20 18:57:580
0		0Form 13D
30FRIEDMAN MICHAEL R.
Director		2026-08-05 16:17:580
0		0Form 4
31Sussman Joel F.
Chief Accounting Officer		2026-08-05 16:19:240
0		0Form 4
32Alleva Lawrence M
Director		2026-08-05 16:22:260
0		0Form 4
33CHANG NANCY T
Director
10% Owner		2026-08-05 16:23:260
0		0Form 4
34LOKAY KEVIN G
Director		2026-08-05 16:23:570
0		0Form 4
35Sorensen Mel
President and CEO		2026-08-05 17:16:360
0		0Form 4